Picard Medical, Inc. (PMI)

Picard Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-24.66	-21.06	-15.57	-11.17
Depreciation & Amortization	0.53	0.54	0.59	0.55
Other Amortization	2.66	2.39	-	-
Loss (Gain) From Sale of Assets	-	-	0.06	-
Stock-Based Compensation	1	0.89	0.13	0.15
Other Operating Activities	6.45	4.4	0.88	1.68
Change in Accounts Receivable	0.84	0.12	0.25	0.21
Change in Inventory	-1.2	-1.33	-0.45	-1.59
Change in Accounts Payable	2.35	2.21	1.61	0.11
Change in Other Net Operating Assets	0.19	-0.03	1.87	-0.65
Operating Cash Flow	-11.86	-11.87	-10.63	-10.72
Capital Expenditures	-	-	-0.01	-0.03
Other Investing Activities	-	-	-0	-0.01
Investing Cash Flow	-	-	-0.01	-0.04
Short-Term Debt Issued	-	9.42	4.92	-
Long-Term Debt Issued	-	3.7	4.16	5.55
Total Debt Issued	13.02	13.12	9.08	5.55
Short-Term Debt Repaid	-	-1.32	-0.88	-
Long-Term Debt Repaid	-	-0.06	-0.01	-0.03
Total Debt Repaid	-1.39	-1.38	-0.89	-0.03
Net Debt Issued (Repaid)	11.63	11.74	8.19	5.52
Financing Cash Flow	12.13	11.74	10.84	5.52
Foreign Exchange Rate Adjustments	0.01	-0.02	-0.11	0.13
Net Cash Flow	0.28	-0.15	0.09	-5.1
Free Cash Flow	-11.86	-11.87	-10.64	-10.75
Free Cash Flow Margin	-391.29%	-270.42%	-211.01%	-261.42%
Free Cash Flow Per Share	-1.49	-1.50	-1.34	-1.92
Cash Interest Paid	-	0	0	0
Cash Income Tax Paid	0.02	-	0	0
Levered Free Cash Flow	5.35	2.22	-2.88	-
Unlevered Free Cash Flow	4.91	1.75	-2.79	-
Change in Working Capital	2.17	0.96	3.28	-1.93

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q